Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Express Scripts
McKinsey
AstraZeneca
McKesson

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Patent: 10,215,746

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 10,215,746
Title:Methods for diagnosis and intervention of hepatic disorders
Abstract: The disclosure provides a method for quantification of hepatic function in a subject comprising measuring the clearance of an orally administered isotopically labeled cholic acid in a subject with, or suspected of having or developing, a hepatic disorder, for example, chronic hepatitis C. The disclosure further provides methods and kits for assessment of hepatic function.
Inventor(s): Everson; Gregory Thomas (Englewood, CO)
Assignee: The Regents of the University of Colorado, a body corporate (Denver, CO)
Application Number:15/195,762
Patent Claims:see list of patent claims

Details for Patent 10,215,746

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 1942-10-21 ⤷  Free Forever Trial 2025-01-26
Baxalta Us Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 1954-03-03 ⤷  Free Forever Trial 2025-01-26
Csl Behring Ag ALBURX albumin (human) Injection 102366 1976-07-23 ⤷  Free Forever Trial 2025-01-26
Grifols Biologicals Llc ALBUTEIN albumin (human) Injection 102478 1978-08-15 ⤷  Free Forever Trial 2025-01-26
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 1995-02-17 ⤷  Free Forever Trial 2025-01-26
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 2003-06-11 ⤷  Free Forever Trial 2025-01-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
McKinsey
Moodys
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.